X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/08/26/2286957/0/en/Avalo-Therapeutics-Inc-Announces-Corporate-Name-Change-from-Cerecor-Inc.html
https://www.globenewswire.com/news-release/2021/08/02/2272725/0/en/Cerecor-Announces-Drawdown-of-10-Million-Tranche-under-its-Debt-Financing-Agreement-with-Horizon-Technology-Finance.html
https://www.globenewswire.com/news-release/2021/08/02/2273153/0/en/Cerecor-Reports-Second-Quarter-2021-Financial-Results-and-Provides-Business-Updates.html
https://www.globenewswire.com/news-release/2021/08/02/2272725/0/en/Cerecor-Announces-Drawdown-of-10-Million-Tranche-under-its-Debt-Financing-Agreement-with-Horizon-Technology-Finance.html
https://www.globenewswire.com/news-release/2021/07/26/2268926/0/en/Cerecor-Announces-Positive-Initial-Phase-1b-Results-for-CERC-002-in-Moderate-to-Severe-Crohn-s-Disease-Patients.html
https://www.globenewswire.com/news-release/2021/05/11/2227025/0/en/FDA-Grants-Fast-Track-Designation-to-CERC-002-for-Treatment-of-Hospitalized-Patients-with-COVID-19.html
https://www.globenewswire.com/news-release/2021/05/05/2223252/0/en/Cerecor-Doses-First-Patient-in-a-Phase-1b-Proof-of-Concept-Clinical-Trial-of-CERC-007-for-the-Treatment-of-Adult-Onset-Still-s-Disease.html
https://www.scienceboard.net/index.aspx?sec=ser&sub=def&pag=dis&ItemID=2401
https://www.globenewswire.com/news-release/2021/03/29/2200614/0/en/Cerecor-Announces-New-Worldwide-License-Agreement-with-Kyowa-Kirin-for-Anti-LIGHT-Antibody-CERC-002.html
https://www.globenewswire.com/news-release/2021/03/08/2189013/0/en/Cerecor-Reports-2020-Financial-Results-and-Provides-Business-Updates.html
Market Place
Share 
